Cleveland Biolabs (CBLI) Reports Q2 Loss of $0.50/Share

Cleveland Biolabs (NASDAQ: CBLI) reported Q2 EPS of ($0.50), versus ($0.17) reported last year.

For earnings history and earnings-related data on Cleveland Biolabs (CBLI) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• JD.com (JD) Reiterated at Buy by Benchmark Amid Earnings Recovery
• Rein Therapeutics Inc. (RNTX) Tops Q2 EPS by 39c